Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement

Lesche, Dorothea; Sigurdardottir, Vilborg; Leichtle, Alexander Benedikt; Nakas, Christos T.; Christians, Uwe; Englberger, Lars; Fiedler, Georg Martin; Largiadèr, Carlo Rodolfo; Mohacsi, Paul; Sistonen, Johanna (2018). Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement. Metabolomics, 14(1), p. 3. Springer 10.1007/s11306-017-1294-8

[img] Text
10.1007_s11306-017-1294-8.pdf - Published Version
Restricted to registered users only until 26 November 2021.
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry

Graduate School:

Graduate School for Cellular and Biomedical Sciences (GCB)

UniBE Contributor:

Lesche, Dorothea; Leichtle, Alexander Benedikt; Nakas, Christos T.; Fiedler, Georg Martin and Largiadèr, Carlo Rodolfo

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1573-3882

Publisher:

Springer

Language:

English

Submitter:

Marie-Christine Müller

Date Deposited:

03 Apr 2019 12:31

Last Modified:

11 Apr 2019 15:14

Publisher DOI:

10.1007/s11306-017-1294-8

PubMed ID:

30830337

BORIS DOI:

10.7892/boris.125814

URI:

https://boris.unibe.ch/id/eprint/125814

Actions (login required)

Edit item Edit item
Provide Feedback